J. P. Patel

Chemical Pathways of Peptide Degradation. VII. Solid State Chemical Instability of an Aspartyl Residue in a Model Hexapeptide

R. Borchardt, C. Oliyai, J. P. Patel, 1994, Pharmaceutical Research.

Urokinase: Stability Studies in Solution and Lyophilized Formulations

J. P. Patel, 1990 .

Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes.

L. T. Tran, J. P. Patel, L. Carr, 1991, American journal of hospital pharmacy.

Enol esters as potential pro-drugs II. In vitro aqueous stability and enzyme-mediated hydrolysis of several enol esters of acetophenone☆

A. Repta, J. P. Patel, 1981 .

Enol esters as potential prodrugs I. Stability and enzyme-mediated hydrolysis of α-acetoxystyrene

A. Repta, J. P. Patel, 1980 .

Evaluation of pain and irritation following local administration of parenteral formulations using the rat paw lick model.

P. Gupta, K. R. Hahn, J. P. Patel, 1994, Journal of pharmaceutical science and technology : the official journal of PDA.

Parenteral formulation development of renin inhibitor Abbott-72517.

D. Jones, S. Gupta, J. P. Patel, 1994, Journal of pharmaceutical science and technology : the official journal of PDA.

Solid state chemical instability of an asparaginyl residue in a model hexapeptide.

R. Borchardt, C. Oliyai, J. P. Patel, 1994, Journal of pharmaceutical science and technology : the official journal of PDA.

Factorial designs in ophthalmic formulation development of Enalkiren

K. Marsh, Kennan Marsh, Jitendra P. Patel, 1990 .

Enol esters as potential prodrugs. IV. Enhanced delivery of the quaternary species coralyne to rat brain using 6′-acetylpapaverin and its enol esters as prodrugs☆

M. Hageman, A. Repta, J. P. Patel, 1982 .